Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, novembre 17
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Faeth Therapeutics Inc
FTH
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$9.28
-0.75
-7.48%
In chiusura: Nov 16, 4:00 PM EST
$9.23
-0.05
-0.54%
Post-mercato: 4:14 PM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Faeth Therapeutics Financials
Faeth Therapeutics (FTH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Crude Oil Falls Over 3%; NRG Energy Shares Jump After Strong Q3 Results
U.S. stocks surged Monday, led by a 2.1% S&P 500 gain; NRG jumped on strong results, while Zura Bio plunged 75% after trial failures.
Avi Kapoor
Dow Jumps Over 600 Points; Constellation Energy Posts Upbeat Earnings
U.S. stocks rallied Monday, led by tech and consumer discretionary shares. Constellation Energy beat Q3 estimates; oil fell while gold rose.
Avi Kapoor
PRO
Faeth Therapeutics Q3 EPS $(0.79) Misses $(0.71) Estimate
Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.71) by 11.27 percent. This is a 78.18 percent increase over losses of $(3.62) per share
Benzinga Newsdesk
PRO
Faeth Therapeutics Q2 EPS $(2.84) Beats $(3.29) Estimate
Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(3.29) by 13.68 percent. This is a 27.37 percent increase over losses of $(3.91) per share
Benzinga Newsdesk